angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with valine in 1 studies
Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (valine) | Trials (valine) | Recent Studies (post-2010) (valine) |
---|---|---|---|---|---|
311 | 5 | 64 | 15,465 | 1,176 | 3,932 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hauner, H; Lee, YM; Skurk, T | 1 |
1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and valine
Article | Year |
---|---|
Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture.
Topics: Adipose Tissue; Adolescent; Adult; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Female; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles; Valine; Valsartan | 2001 |